These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1710317)

  • 1. Immunosuppression. Binding by design.
    Ringe D
    Nature; 1991 May; 351(6323):185-6. PubMed ID: 1710317
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure-function relationships in the FK506-binding protein (FKBP) family of peptidylprolyl cis-trans isomerases.
    Kay JE
    Biochem J; 1996 Mar; 314 ( Pt 2)(Pt 2):361-85. PubMed ID: 8670043
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunophilin structure: a template for immunosuppressive drug design?
    Walkinshaw MD; Kallen J; Weber HP; Widmer A; Widmer H; Zurini M
    Transplant Proc; 1992 Aug; 24(4 Suppl 2):8-13. PubMed ID: 1496694
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunosuppression. Convergence of drug action.
    Freedman RB
    Nature; 1989 Oct; 341(6244):692. PubMed ID: 2477712
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunophilins and immunosuppression by cyclosporins and macrolide structures.
    Schreier MH
    Acta Derm Venereol Suppl (Stockh); 1994; 186():100. PubMed ID: 7521103
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporin A, FK506, and rapamycin: binding to immunophilins and biological action.
    Bierer BE
    Chem Immunol; 1994; 59():128-55. PubMed ID: 7524531
    [No Abstract]   [Full Text] [Related]  

  • 7. A nonimmunosuppressive triene-modified rapamycin analog is a potent inhibitor of peptidyl prolyl cis-trans isomerase.
    Ocain TD; Longhi D; Steffan RJ; Caccese RG; Sehgal SN
    Biochem Biophys Res Commun; 1993 May; 192(3):1340-6. PubMed ID: 7685167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential roles of other FK 506-binding proteins in mediating the effects of FK 506.
    Siekierka JJ; Wiederrecht G; Cryan J; Hung SH; Comisky M; Sigal NH
    Transplant Proc; 1991 Dec; 23(6):2720-1. PubMed ID: 1721256
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemistry and biology of the immunophilins and their immunosuppressive ligands.
    Schreiber SL
    Science; 1991 Jan; 251(4991):283-7. PubMed ID: 1702904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin.
    Siekierka JJ; Hung SH; Poe M; Lin CS; Sigal NH
    Nature; 1989 Oct; 341(6244):755-7. PubMed ID: 2477714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is FKBP involved in the immunosuppressive and/or toxic mechanism of action of FK 506?
    Sigal NH; Dumont FJ; Siekierka JJ; Wiederrecht G; Parent SA; Brizuela L
    Transplant Proc; 1991 Dec; 23(6):2846-9. PubMed ID: 1721295
    [No Abstract]   [Full Text] [Related]  

  • 12. Gene expression of FK 506-binding protein.
    Kar S; Carr B
    Transplant Proc; 1991 Dec; 23(6):2880-2. PubMed ID: 1721303
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclophilin binding: a more accurate measure of cyclosporine immunosuppressive activity after renal transplantation.
    Paul K; Harding MW; Marks WH; Handschumacher RE; Lorber MI
    Transplant Proc; 1991 Feb; 23(1 Pt 2):974-5. PubMed ID: 1989349
    [No Abstract]   [Full Text] [Related]  

  • 14. Isomerase modification.
    Rakitzis ET
    Nature; 1989 Aug; 340(6232):351-2. PubMed ID: 2666859
    [No Abstract]   [Full Text] [Related]  

  • 15. When worlds collide: immunosuppressants meet protein phosphatases.
    McKeon F
    Cell; 1991 Sep; 66(5):823-6. PubMed ID: 1716181
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanism of action of FK 506 and cyclosporin.
    Steinmann B; Superti-Furga A; Bruckner P
    Lancet; 1991 Feb; 337(8738):439. PubMed ID: 1704088
    [No Abstract]   [Full Text] [Related]  

  • 17. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase.
    Harding MW; Galat A; Uehling DE; Schreiber SL
    Nature; 1989 Oct; 341(6244):758-60. PubMed ID: 2477715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine suppression of intracellular activation signal generation is not mediated by prolyl-peptidyl isomerase.
    Kimball PM; Kerman RH; Kahan BD
    Transplant Proc; 1991 Feb; 23(1 Pt 1):323-4. PubMed ID: 1990544
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of T-cell signaling pathways by immunophilin drug complexes: are side effects inherent to immunosuppressive properties?
    Schreier MH; Baumann G; Zenke G
    Transplant Proc; 1993 Feb; 25(1 Pt 1):502-7. PubMed ID: 7679818
    [No Abstract]   [Full Text] [Related]  

  • 20. Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics.
    Starzl TE; Abu-Elmagd K; Tzakis A; Fung JJ; Porter KA; Todo S
    Transplant Proc; 1991 Feb; 23(1 Pt 2):914-9. PubMed ID: 1703351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.